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ObJectives. This study sought to develop a dual-isotope single- 
acquisition single-photon emission computed tomographic 
(SPECT) protocol using a multihead SPECT camera equipped 
with an ultra-high energy collimator to evaluate rest metabolism/ 
stress perfusion simultaneously with fluorine-18 (F-18) deoxyglucose/ 
technetium-99m (Tc-99m) 2-hexakis-2-methoxy-2-methylpropyl isoni- 
trile (MIBI). 
Background. The most accurate and logistic method f identi- 
fying injured but viable myocardium remains a diagnostic chal- 
lenge. 
Methods. Sixty-five patients were given 25 to50 g of glucose and, 
after -60 min, an injection of 370 MBq (10 mCi) of F-18 fluorode- 
oxyglucose. After a 35-min distribution phase, patients underwent 
exercise or pharmacologic stress followed by administration f925 
MBq (25 mCi) of Tc-99m MIBI. Five patients underwent F-18 
fluorodeoxyglucose positron emission tomography before dual- 
isotope SPECT. 
Results. With a window of 20% for both photopeaks and a 
technetium-99m/fluorine-18 concentration of 3.2:1,the "spiliover" 
from fluorine-18 into the technetium-99m window is <6% of the 
total counts in the window in patients with a normal distribution 
of both radiopharmaceuticals. Phantom images clearly demon- 
strated cardiac defects measuring 2 x 1 and2 x 0.5 cm. There 
was no significant difference i  the images of the five patients who 
underwent both positron emission tomography and SPECT. Fifty- 
seven patients (mean [+SD] age 55 + 15 years, range 25to 83; 38 
men, 19 women) had satisfactory images andwere included in the 
study. Twenty-one patients had normal study results; 15 had 
mismatched defects; 14 had matched defects; and 7 had both 
matched and mismatched defects. Twenty.three patients (mean 
age 54 -+ 6 years, range 30 to 83; 14 men, 9 women) underwent 
coronary angiography within 3 months of dual-isotope SPECT. 
There were seven ormal studies, eight with mismatched defects, 
one with a matched defect and seven with matched and mis- 
matched defects. When stenosis >70% was used as the criterion 
for a diagnosis of coronary artery disease, dual-isotope SPECT 
had a sensitivity of 100%, specificity of 88%, positive predictive 
value of 93%, negative predictive value of 100% and an accuracy of 
96%. 
Conclusions. Dual-isotope SPECT may provide an alternative, 
accurate, cost-effective method to nitrogen-13 ammonia/F-18 
fluorodeoxyglucose positron emission tomography or thallium- 
201 reinjection for identifying injured or dysfunctional but viable 
myocardium. 
(JAm Coil Cardiol 1995;26:870-8) 
Myocardial perfusion can be evaluated with thallium-201 
chloride, technetium-99m (Tc-99m) 2-hexakis-2-methoxy-2- 
methylpropyl isonitrile (MIBI) single-photon emission tomog- 
raphy (SPECT) or with nitrogen-13 (N-13) ammonia positron 
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emission tomography (1). Myocardial glucose metabolism can 
be evaluated with fluorine-18 (F-18) fluorodeoxyglucose, fatty 
acid metabolism with carbon- 11 (C- 11) palmitate and oxidative 
metabolism with C-11 acetate (1). 
Recent modifications of thallium-201 SPECT protocols that 
include 24-h delayed imaging or imaging after reinjection of 
thallium-201 up to 24 h have improved the detection of viable 
myocardium when F-18 fluorodeoxyglucose positron emission 
tomography is not available (1). However, these protocols have 
been shown (2,3) to underestimate myocardial viability. 
The feasibility of performing cardiac SPECT with F-18 
fluorodeoxyglucose hasbeen demonstrated byseveral investi- 
gators (4-7). The purpose of the present study was to develop 
a simultaneous dual-isotope single-acquisition protocol using a 
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multihead SPECT camera equipped with ultra-high energy 
collimators to simultaneously evaluate rest cardiac metabolism 
with F-18 fluorodeoxyglucose and stress cardiac perfusion with 
Tc-99m MIBI. 
Methods  
Equipment and physical measurements. Dual-isotope 
(fluorine-18 and technetium-99m) SPECT imaging was per- 
formed using an Apex Helix dual-head, rectangular field-of- 
view digital scintillation camera (Elscint, Inc.) modified by the 
manufacturer to permit imaging of 511-keV photons in the 
single noncoincidence mode (7). Positron emission tomogra- 
phy was performed with a Siemens 933/08/16 tomograph with 
previously described specifications (7). 
A set of ultra-high energy collimators were designed to 
support ultra-high energy, general-purpose whole-body and 
SPECT applications (7). Methods of measurements of system 
planar and SPECT sensitivity and spatial resolution have been
described previously (7). 
Image acquisitions of 30-min duration were performed on 
the SPECT and positron emission tomographic systems using 
a Data Spectrum cardiac phantom containing 300 ~Ci ot" 
fluorine-18 and placed in a 22-cm diameter water-filled cylin- 
dric phantom. A 13-cm radius ofrotation was used for SPECT 
imaging. The phantom contained two simulated 45 o defects: 
one 2 × 1 cm and the other 2 × 0.5 cm. Data were collected 
separately for the two heads of the camera system using the 
dual-isotope technique, which enables simultaneous acquisi- 
tion in two energy windows and a 360 ° rotation. The SPECT 
reconstruction was accomplished from the fluorine-18 window 
for the single anterior detector alone (180 ° acquisition) and for 
both detectors together (360 ° acquisition). Image comparisons 
were performed to determine the optimal acquisition protocol. 
In addition, SPECT image reconstruction was also accom- 
plished from the technetium-99m window t  evaluate the 
contribution of scatter from fluorine-18 into the technetium- 
99m window. Total counts from the heart phantom were 
determined for both windows. A solution f technetium-99m 
was then added to the phantom, and the dual-isotope SPECT 
image acquisition was repeated. The activity of technetium- 
99m was calculated o provide a technetium-99m/fluorine-18 
ratio of 3.2:1 to simulate the ratio f activities in the myocar- 
dium at the time of imaging after the dual-isotope SPECT 
protocol. This ratio was calculated by decaying the adminis- 
tered doses of fluorine-18 and technetium-99m to the start of
acquisition in the clinical protocol and assuming identical 
percent uptakes for the two radiopharmaceuticals. The ratio 
was verified by collecting an energy spectrum from the phan- 
tom and from a patient with the scintillation camera positioned 
for an anterior view. Reconstructed SPECT images were 
compared for the two windows to evaluate the potential 
diagnostic quality of the dual-isotope technique with the 
ultra-high energy collimator. 
Total counts from the art recorded in the two windows 
were determined in five patients who underwent imaging using 
Table 1. Patient Demographics 
Patients With 
All Patients Angiography 
(n = 57) (n = 23) 
Men 38 (67) 14/9 (61/39) 
Women 19 (33) 
Age (yr) 
Mean + SD 55 _+ 15 54 _+ 16 
Range 25-83 30-83 
History of CAD 43 (75) 20 (87) 
Bypass graft 14 (25) 6 (26) 
Beta-blockers 20 (35) 8 (35) 
Exercise 39 (68) 16 (70) 
Dipyridamole 17 (30) 7 (30) 
Data presented are number (%) of patients, unless otherwise indicated. 
the dual-isotope protocol and were reported to have normal 
distributions of both radiopharmaceuticals with normal find- 
ings on coronary angiography so as to determine the contribu- 
tion of downscatter f om the fluorine-18 to the technetium- 
99m window. 
An additional set of data was obtained to evaluate the 
effects of fluorine-18 downscatter in a region of ischemia in a 
heart where the global perfusion is reduced. Two-centimeter 
diameter vials were filled with solutions of technetium-99m 
and fluorine-18 to simulate normal (technetium-99m/ 
fluorine-18 3.2:1), 75% normal (technetium-99m/fluorine-18 
2.4:1), 50% normal (technetium-99m/fluorine-18 1.6:1) and 
25% normal (technetium-99m/fluorine-18 0.8:1) global perfu- 
sion (vial A). For each of these conditions, additional vials 
were filled with solutions f technetium-99m and fluorine-18 to 
represent regions of 100%, 75%, 50%, 25% and 0% ischemia 
(vial B). A constant activity of fluorine-18 (100/~Ci) was used 
in all vials representing normal yocardial metabolism. These 
vials were then imaged at a constant ime using the dual- 
isotope technique, and technetium-99m window c unts were 
determined from each vial using a circular region of interest 
that just included the vial. Measured percent contrast between 
the simulated ischemic and normal myocardium [(technetium- 
99m window counts in vial B/technetium-99m window counts 
in vial A) x 100] was calculated from each of the samples. 
Data for different activities of fluorine-18 (up to four times 
normal) were then extrapolated from this data set to simulate 
increased amounts of metabolism in the presence of varying 
degrees of ischemia. 
Patients. Rest F-18 fluorodeoxyglucose/stress Tc-99m 
MIBI dual-isotope SPECT imaging was performed on 65 
patients referred for evaluation of myocardial ischemia. Eight 
patients were excluded because of movement artifact (n = 2), 
poor image quality secondary to massive obesity (n = 1) and 
poor F-18 fluorodeoxyglucose uptake secondary to diabetes 
(n = 5). The demographic data for the 57 patients included in 
the study are summarized in Table 1. A subgroup of 23 patients 
underwent coronary angiography within 3 months of dual- 
isotope SPECT. Five patients underwent rest F-18 fluorode- 
oxyglucose positron emission tomographic imaging before 
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Figure 1. Schematic of the rest/stress dual-isotope single-acquisition 
SPECT protocol for fluorine-18 fluorodeoxyglucose (I~FDG)/ 
technetium-99m (99mTc) MIBI, 
stress and imaging with dual-isotope SPECT. This protocol 
was approved by the Vanderbilt University Medical Center 
Institutional Review Board, and all participants gave written 
informed consent. 
Fluorine-18 fluorodeoxyglucose positron emission tomo. 
graphic imaging. Positron emission tomographic imaging was 
performed in five patients before dual-isotope SPECT, as 
previously described (7). After completion of positron emis- 
sion tomographic imaging, the patients underwent s ress test- 
ing and then imaging with the dual-isotope simultaneous 
acquisition protocol, as described later (Fig. 1), 
Fluorine-18 fluorodeoxyglucose/Tc-99m MIBI dual-isotope 
rest/stress cardiac protocol. Rest F-18 fluorodeoxyglucose ad- 
ministration. Patients fasted for a minimum of 4 h before the 
study. All patients were given 25 to 50 g of oral glucose 
-60 rain before injection of 370 MBq (10 mCi) of F-18 
fluorodeoxyglucose, and soluble insulin was dministered if 
necessary according to blood glucose levels. After a 45-rain 
uptake phase, patients underwent s ress testing using a stan- 
dard graded exercise treadmill test or pharmacologic stress 
testing with dipyridamole (0.72 mg/kg body weight infused over 
5 rain). 
Technetium-99m MIBI administration. A dose of 925 MBq 
(25 mCi) Tc-99m MIBI was administered intravenously at 
peak exercise or 2 rain after dipyridamole infusion. Dual- 
isotope SPECT was started 15 to 30 rain after administration f 
Tc-99m MIBI. 
Dual-isotope single-acquisition SPECT protocol. The acqui- 
sition protocol included a single h ad rotating 180 ° from the 
right anterior oblique to the left posterior oblique projection 
for 60 stops at 30 s/stop. The images from the two energy 
windows (20% from both photopeaks) were collected in sep- 
arate 64 x 64 matrices using word mode and then recon- 
structed using a Butterworth filter and temporal smoothing 
along the short axis, horizontal long axis and vertical long 
axis of the heart. Thus, two separate sets of slices mapping 
the Tc-99m MIBI and F-18 fluorodeoxyglucose distributions 
were obtained with one-to-one correspondence in spatial 
registration. 
Image analysis. Positron emission tomographic and 
SPECT images were reoriented along the short axis of the 
heart with slices of the same thickness. As with the phantom 
studies, images were normalized to the pixel containing the 
maximal number of counts in each radionuclide data set. The 
rest F-18 fluorodeoxyglucose/stress Tc-99m MIBI images were 
interpreted independently b two experienced observers with- 
out previous knowledge of other study results, including elec- 
trocardiography, clinical and hemodynamic response to the 
functional study as well as recent cardiac angiography if this 
had been done. Qualitative analysis was performed using a 
nine-segment model/study: an apical segment as well as distal 
and proximal (basal) segments of the anterior, inferior, lateral 
and septal walls. Segments were classified into three catego- 
ries: 1) normal = good F-18 fluorodeoxyglucose and Tc-99m 
MIBI uptake; 2) mismatched efect = moderate to severe 
decreased uptake of Tc-99m MIBI but adequate F-18 fluoro- 
deoxyglucose uptake, suggesting either acute ischemia or hi- 
bernating myocardium; 3) matched defects = moderate to 
severe decreased uptake of both Tc-99m MIBI and F-18 
fluorodeoxyglucose indicative of scar. 
Coronary angiography. Coronary angiography was per- 
formed in multiple orthogonal projections, and single and 
biplane left ventriculograms were obtained. Cineangiograms 
were assessed by an experienced angiographer unaware of both 
clinical and scintigraphic data. Extent of coronary artery 
disease was defined as number of vessels with a stenosis >70%, 
or in patients with coronary artery b pass graft surgery, both 
the native vessel as well as the graft supplying that vascular 
distribution required >70% stenosis to be considered a hemo- 
dynamically significant stenosis. 
Interpretation of data. The ability of F-18 fluorodeoxyglu- 
cose/Tc-99m MIBI dual-isotope SPECT topredict involvement 
of individual coronary vessels was assessed by ascribing the 
septum and anterior walls to the left anterior descending coronary 
artery, the lateral wall to the left circumflex coronary artery and 
the inferior wall to the right coronary artery, except in cases where 
coronary angiography revealed a left-dominant system. I  the e 
cases both inferior and lateral walls were ascribed to the left 
circumflex vessel. The apex was allocated o any other involved 
territory. However, if the apex alone was involved, the left 
anterior descending coronary artery was implicated. 
Statistical analysis. Patient demographic data are ex- 
pressed as mean value _+ SD. Sensitivity, specificity, positive 
and negative predictive values and accuracy of results were 
determined using standard formulas. 
Resul ts  
Physical measurements. The single-detector system sensi- 
tivity for the dual-head camera with the ultra-high energy 
collimator was measured to be 129 cpm/~Ci, including pene- 
tration, for fluorine-18 and 114 cpm//xCi for technetium-99m. 
Excluding penetration, the system sensitivity was calculated to 
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Figure 2. Single-photon emission computed tomo- 
graphic images using the ultra-high energy, collima- 
tor of the Data Spectrum cardiac phantom contain- 
ing a solution of F-t8 fluorodeoxyglucose alone 
and embedded in a 22-cm diameter water-filled 
phantom and with a solution f technetium-99m 
added in a concentration of 3.2:1. A, Fluorine-18 in
fluorine-18 window. B, Fluorine-18 intechnetium- 
99m window. C, Technetium-99m and fluorine-18 
in technetium-99m window. Simulated lesions are
indicated by arrows. 
be 62 cpm/t~Ci for fluorine-18. Planar system spatial resolution 
measurements at 10 cm in air indicated that the spatial 
resolution for technetium-99m (11.1 mm) was superior to that 
for fluorine-18 (14.5 ram) using the ultra-high energy collima- 
tor. However, the spatial resolution for technetium-99m was 
inferior to that routinely obtained with the low energy, high 
resolution collimator (8.4 ram). The SPECT spatial resolution 
measurements with scatter yielded measurements of 14.6 and 
17.0 mm for technetium-99m and fluorine-18, respectively for 
the ultra-high energy collimator. The SPECT dual-head vol- 
ume sensitivity measurements yielded values of 125 and 
270 cpm//xCi for technetium-99m and fluorine-18, respectively. 
For the positron emission tomographic scanner, spatial 
resolution with fluorine-18 within an 8-ram slice was measured 
and found to be 6.5 ram, yielding a voxel size of 6.5 x 6.5 x 
8 ram. Volume sensitivity was measured and found to be 2,238 
cpm//~Ci. When dual-head SPECT was compared with 
positron emission tomography for 511-keV imaging, it was 
apparent that the measured reconstructed spatial resolution 
was lower by a factor of 2.6, and volume sensitivity was lower 
by a factor of 8. 
With the Data Spectrum cardiac phantom, acomparison of 
reconstructed images from the single anterior detector of the 
dual-head SPECT system (180 ° acquisition) versus both detec- 
tors together (360 ° acquisition) shows the image quality to be 
slightly superior for the single-head acquisition. Comparable 
images of 8-mm thick slices in the short-axis view of the 
phantom using the positron emission tomographic s anner and 
the SPECT camera with a single-head 180 ° acquisition dem- 
onstrated the superior spatial resolution of positron emission 
tomography. This was apparent in the thin, well defined walls 
of the phantom (1 cm thick) and in the definition of the two 
lesions. However, the image from the SPECT camera with the 
ultra-high energy collimator demonstrated that F-18 fluorode- 
oxyglucose SPECT can resolve cold defects of 2 x 0.5 cm in the 
heart (7). 
Figure 2 shows selected SPECT images of the cardiac 
phantom containing fluorine-18 alone and imaged with the 
dual-isotope technique. The first set of images was obtained 
with the fluorine-18 window and the second set from the 
technetium-99m window. Images were normalized to the pixel 
containing the maximal number of counts in the complete 
study. Measurements of total counts from the heart phantom 
in the two windows indicated that downscatter into the 
technetium-99m window for the Apex Helix was 31% of the 
counts recorded in the fluorine-18 window. The third set of 
images was obtained after adding a solution of technetium- 
99m to the phantom in a concentration 3.2 times that of 
fluorine-18 and independently normalized to the maximal 
count in the technetium-99m i age. The high quality of the 
reconstructed images is evident for both windows (first and 
third image sets), with both simulated lesions being clearly 
defined. The two data sets also clearly indicate the direct image 
comparison capability with e one to one correspondence of 
comparable slices provided by the simultaneous dual-isotope 
imaging technique. By measuring the total counts in the 
technetium-99m window from the cardiac phantom and assum- 
ing that 31% of the counts from the fluorine-18 peak appear in 
the technetium-99m window, it was determined that only 5.9% 
of the counts in the technetium-99m window represented 
downscatter from fluorine-18. Figure 3 shows an energy spec- 
trum from technetium-99m and fluorine-18 in the 3.2:1 con- 
centration ratio clearly indicating the ability to resolve the 
technetium-99m photopeak from the other structures in the 
spectrum. Energy spectra from the cardiac phantom and a 
patient with normal global perfusion and normal cardiac 
metabolism were virtually identical when superimposed, veri- 
fying the 3.2:1 ratio in normal global perfusion and metabo- 
lism. 
Total counts from the heart were determined for the two 
energy windows in five patients imaged with the dual-isotope 
protocol and who were reported as having normal distribution 
of both radiopharmaceuticals. A suming 31% downscatter 
from fluorine-18 as measured from the phantom study, the 
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Figure 3. Energy spectrum from technetium-99m (99mTc) and 
fluorine-18 (iSF) in a 3.2:1 ratio of activities, respectively, obtained 
with the dual-head SPECT camera. 
average contribution to the technetium-99m window was mea- 
sured to be 3.7% to 6.6% of the total counts measured in the 
technetium-99m window, which agreed with the phantom 
measurements. 
In imaging situations where global perfusion is reduced and 
regions of ischemia are identified, the percent contribution of 
fluorine-18 downscatter o the technetium-99m window will be 
>5.9%. Table 2 shows the results of the sample counting 
experiment o evaluate this effect. For the four global perfu- 
sion rates chosen (normal to 25% normal), five data sets 
representing 100% to 0% ischemia were evaluated. In each of
these cases, the effect of fluorine-18 downscatter was measured 
or calculated from the measurements for a range of up to four 
times the activity representing normal metabolism. (Note that 
for this experiment, 100 ~Ci of fluorine-18 represents normal 
metabolism, and 320 ~Ci of technetium-99m represents nor- 
mal perfusion, i.e., 3.2:1). The measured percent contrast 
values (ischemic region/normal myocardium x 100 based on 
technetium-99m window counts) are shown for the case of 
normal metabolism along with the range of values for up to 
four times normal. These values can be compared with the 
actual values that are determined by the ratio of technetium- 
99m activities in the two samples. 
Clinical results. Rest F-18 fluorodeoxyglucose positron 
emission tomographic images obtained before stress testing 
and Tc-99m MIBI injection were compared with F-18 
fluorodeoxyglucose SPECT images obtained with the dual- 
isotope protocol in five patients. These two sets of images 
showed no significant difference, confirming that the F-18 
fluorodeoxyglucose distribution was not qualitatively altered 
by stress. 
Of the 57 patients, 21 had normal F-18 fluorodeoxyglucose/ 
Tc-99m MIBI study results, 15 patients had only mismatched 
Table 2. Measurement of the Effect of Fluorine-18 Downscatter Into the Technetium-99m Window in Simultaneous Dual-lsotope Study 
Actual %B/A 
Global Perfusion Determined by Perccm 
Tc-99m Activity (,aCi) Simulated lschemia of Tc-99m Activity {A) 
in A in B in B 
Measured %B/A for Normal 
Metabolism (100 tzCi of F-18 
in A and B) 
Calculated %B/A for Range of
Metabolism (100-400 ~Ci of F-18 
in A and B) 
320 (normal) ll)0~:; ~ Off 5% 5-17% 
75ci 25% 28% 28-37% 
50c; 50% 54% 54-60% 
25 ~ 75 % 76% 76 -79% 
0 c; 11)0% 100% 100% 
240 (75% normal) l(X)C; 0% 6% 6-21% 
75'~ 25q 3(1% 30-42% 
50c:~ 509~- 54% 54-61% 
25~ 75 f4 78% 78-81% 
()c;~ 1005~ 100% 100% 
160 (50% normal) 100~i 0c/- 9% 9-28% 
75 ~;i 25 c~ 33% 33- 47% 
5()~i: 50~ 52% 52-62% 
25~ 75% 76% 76-81% 
0q 100~ 100% 100% 
80 (25% normal) 10()c~ 0% 17% 17-45% 
75c~ 25% 41% 41-61% 
50~i 50c~ 63% 63-76% 
25~; 75~ 85% 85-89% 
lit; 100% 100% 100% 
Vial A represents the myocardium, and vial B represents an area of ischemia. Percent contrast (ischemic area to normal myocardium) is measured by %B/A 
determined by detected counts in the technetium-99m (Tc-99m) window. The column labeled "Actual" is determined by the ratio of technetium-99m activities and 
corresponds to 100% to 0% ischemia. Percent contrast was measured for a simulation of normal metabolism (100 ~Ci of fluorine-18 [F-18] in vials A and B). Percent 
contrast was calculated for up to four times normal metabolism. These values are measured/calculated for four simulated conditions of global perfusion: normal, 75% 
normal, 50% normal and 25% normal. The normal ratio (3.2:1) is represented by 320 gCi of technetium-99m and 100 ,aCi of fluorine-18 in vials A and B. 
JACC Vol. 26, No. 4 SANDLER ET AL. 875 
October 1995:870-8 DUAL-ISOTOPE EVALUATION OF ISCHEMIA 
Figure 4. Images from a 34-year old man wJ 
severe two-vessel disease with a previot 
myocardial infarction. A, Short-axis F-I 
(FDG)/Tc-99m MIBI dual-isotope SPEC" 
ischemia of the anteroseptal andinferior w: 
(arrowheads). B, Horizontal long-axis F-( 
Tc-99m MIBI dual-isotope SPECT images 
tissue in the apex of the left ventricle (a 
ischemia. C,Coronary angiogram in the riglr 
identifying a severe proximal left anterio 
artery stenosis and an attenuated distal e 
coronary artery with Thrombolysis in Myoc 
2 flow. Collateral vessels are seen from the 1 
and left circumflex coronary artery distJ 
posterior descending branch of an occludec 
A 
B C 
defects indicative of ischemia, 14 patients had only matched 
defects indicative of scar, and 7 patients had both matched and 
mismatched efects. A typical scan of a patient with both 
matched and mismatched defects is shown in Figure 4. 
Table 3 shows the correlation between F-18 fluorodeoxy- 
glucose/Tc-99m MIBI scintigraphy and angiography in the 23 
patients who underwent coronary angiography. Among the 
Table 3. Correlation Between Fluorine-18 Fluorodeoxyglucose/ 
Technetium-99m MIBI Scan and Angiography 
Negative Results Positive Results 
on Angiography on Angiography Total 
Normal 7 TN 0 FN 7 
Mismatched efects only 1 FP 7 TP 8 
Matched defects only 1 TN I) FN ] 
Mismatched and matched 0 FP 7 TP 7 
defects 
Total 9 14 23 
FN = false negative: FP = false positive; TN - true negative; TP =truc 
positive. 
seven patients with normal F-18 fluorodeoxyglucose/Tc-99m 
MIBI scan results and no significant lesions onthe angiogram, 
two had no known coronary artery disease but presented with 
chest pain on several occasions. Although four other patients 
had known coronary artery disease, angiography demonstrated 
mild coronary artery disease in one patient (<50% stenosis); 
one patient had a patent vessel in a region of previous 
successful percutaneous transluminal angioplasty; and two 
patients had patent coronary bypass grafts. The patient with a 
matched defect (inferior wall) had a documented recent 
inferior myocardial infarction with follow-up lytic therapy. The 
angiogram revealed a residual 60% stenosis of the right 
coronary artery and severe inferior wall hypokinesia. Eight 
patients had mismatched defects only. Of these eight patients, 
one had no documented history of coronary artery disease, and 
seven had known coronary artery disease. The single patient 
with a mismatched defect (anterior wall) and no significant 
coronary artery disease on the angiography (false positive 
result) had a history of anteroseptal myocardial infarction with 
a patent graft to the left anterior descending coronary artery. 
876 SANDLER ET AL. JACC Vol. 26, No. 4 
DUAL-ISOTOPE EVALUATION OF ISCHEMIA October 1995:870-8 
100 
8O 
o,) 
E 
o~ 60 u~ 
,o "E 
,o 
~_ 2o 
LAD RCA Circumflex 
Figure 5. Angiographic distribution of the segmental p ttern of up- 
take according to coronary artery distribution for 23 patients. LAD - 
left anterior descending coronary artery; RCA = right coronary artery. 
The remaining seven patients with only mismatched efects 
had angiographic stenosis corresponding tothe regional distri- 
butions of these defects. All seven patients with both matched 
and mismatched efects had documented myocardial infarc- 
tion with wall motion abnormalities on the left ventricuiogram 
(in one patient, the left ventriculogram was not obtained). Six 
of these patients had evidence of ischemia in the same vascular 
distribution as the previous myocardial infarction, and one in 
another vascular distribution. 
A total of 513 segments were analyzed, and the segmental 
patterns of uptake (normal, matched efects and mismatched 
defects) according to the three individual coronary artery 
distribution were similar for all patients (n = 57) and for the 
patients who underwent coronary angiography (n = 23) (Fig. 
5). The one false positive scan w s in the left anterior descending 
coronary artery distribution, with the coronary angiogram show- 
ing no evidence of left anterior descending coronary artery 
stenosis despite the presence of a mismatched defect on the F-18 
fluorodeoxyglucose/Tc-99m MIBI scan. 
The interpretation by the two independent observers 
agreed in 489 (95%) of 513 segments. In all but one of the 
patients, the disagreement was related to the extent of the 
defects but not to the vascular territory involved. In only one 
patient did the two bservers differ on the diagnosis. 
In the 23 patients who had coronary angiography, the 
sensitivity and specificity of F-18 fluorodeoxyglucose/Tc-99m 
MIBI dual-isotope single acquisition SPECT protocol to detect 
coronary artery disease were 100% and 88%, respectively, with 
a positive predictive value of 93%, a negative predictive value 
of 100% and an accuracy of 96%. 
Discuss ion 
Previous work in our laboratory (7) has demonstrated the 
ability of the modified Apex dual-head helix (Elscint, Inc.) 
fitted with ultra-high energy collimators to provide excellent 
quality images of the heart using F-18 ftuorodeoxyglucose. 
Sequential acquisition cardiac studies to evaluate for hiber- 
nating myocardium with F-18 fluorodeoxyglucose SPECT, 
thallium-201 or Tc-99m MIBI SPECT have been performed 
and appear to supply comparable diagnostic quality images 
and adequate clinical information compared with that for N-13 
ammonia/F-18 fluorodeoxyglucose positron emission tomogra- 
phy (4-7). In the present study we developed a new method- 
ology using a rest metabolism/stress perfusion protocol with 
F-18 fluorodeoxyglucose/Tc-99m MIBI followed by dual- 
isotope SPECT that can identify both acute cardiac ischemia 
and hibernating myocardium in patients with left ventricular 
dysfunction. Experimental data from the present study using 
simulated myocardial distributions of technetium-99m/ 
fluorine-18 revealed that the downscatter contribution from 
fluorine-18 into the technetium-99m i age becomes theoreti- 
cally significant in regions of severe ischemia (75% to 100%), 
with a fourfold increase in metabolism when associated with a 
twofold decrease in global perfusion. 
The data in the present s udy from the 23 patients who 
underwent coronary angiography demonstrated a sensitivity of 
100%, specificity of 88% and accuracy of 96% for a diagnosis 
of coronary artery disease >70% stenosis. These data are com- 
parable to those reported (8,9) for thallium-201 stress SPECT 
imaging (sensitivity 96%, specificity 70% o85%) for the diagno- 
sis of coronary artery disease. 
Advantages of rest F-18 fluorodeoxyglueose/stress Tc-99m 
MIBI dual-isotope SPECT. The ability to identify hibernating 
myocardium or chronic coronary artery disease, or both, by 
evaluating myocardial metabolism directly with F-18 fluorode- 
oxyglucose SPECT using the dual-isotope SPECT protocol is a 
significant advantage over either thallium-201 or technetium- 
99m MIBI stress/rest protocols. 
Several studies have shown that 38% to 50% of the irrevers- 
ible defects on stress/4-h redistribution thallium-201 studies show 
metabolic activity with positron emission t mography and im- 
prove after revascularization. Delayed 24-h imaging shows redis- 
tribution in 21% to 61% of the segments with a fixed stress/4-h 
redistribution defect. Among the segments with late redistribu- 
tion, 95% improve after revascularization. However, 37% of the 
segments with a fixed d fect on both 4- and 24-h images also 
improve after revascularization, indicating that 24-h images still 
underestimate he presence of viable myocardium (1). Reinjec- 
tion of thallium-201 before redistribution imaging demonstrates 
reversibility in 31% to 49% of segments with fixed defects on 
stress/4-h redistribution images (1). Most of the segments (80% to 
87%) showing reversibility on reinjection images improved after 
revascularization, whereas only 0% to18% of irreversible defects 
on both 4-h and reinjection images improved afterrevasculariza- 
tion (1). 
Numerous groups of investigators have confirmed these 
data but have also demonstrated F-18 fluorodeoxyglucose 
metabolism (2,3) and regional wall motion improvement after 
revascularization in 25% of segments with a fixed efect using 
thallium-201 reinjection (4) and most segments with persistent 
24-h thallium-201 defects (3). 
Several studies (10) have reported that Tc-99m MIBI may 
be an accurate marker of viability in the setting of stunned 
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myocardium after reperfusion after acute myocardial infarc- 
tion. With respect o evaluation of myocardial viability in 
patients with chronic ischemia nd left ventricular dysfunction, 
more recent data (11) show that regions with severe reduction 
of Tc-99m MIBI uptake on both stress and rest images may 
have a reversible defect on thallium-201 reinjection and there- 
fore contain viable myocardium. Preliminary data have shown 
F-18 fluorodeoxyglucose uptake in regions that had reversible 
thallium-201 uptake with a fixed Tc-99m MIBI defect (12). 
Therefore at present, it appears that stress/rest Tc-99m MIBI 
studies underestimate he presence of viable myocardium in 
patients with chronic ischemic heart disease and left ventricu- 
lar dysfunction. 
Another marker of myocardial viability that is being inves- 
tigated clinically to detect hibernating myocardium is the 
evaluation of regional systolic wall thickening using dobut- 
amine echocardiography because recent reports (13) indicate 
that isotropic reserve is maintained in hibernating myocar- 
dium. Preliminary studies (13) with a small number of patients 
support the possibility of dobutamine chocardiography to 
predict postvascularization recovery, with a sensitivity and 
specificity comparable to that of delayed thallium-201 imaging. 
The choice of Tc-99m MIBI over thallium-201 for the stress 
part of the dual-isotope SPECT protocol relates to the fact that 
the 140-keV photons from the technetium-99m component 
and injectable doses of up to 925 MBq/70 kg result in improved 
count density and image resolution compared with that for 
thallium-201 when imaging is done with ultra-high energy 
collimators. A further advantage of using Tc-99m MIBI is the 
ability to perform gated cardiac images with dual-isotope 
SPECT to assess wall motion as well as the potential to obtain 
volume-determined ejection fraction values. 
Other advantages of dual-isotope SPECT include patient 
convenience, shorter length of image acquisition and perfect 
registration of the two sets of images. The larger axial field of
view of most gamma cameras (40 cm for the Apex Helix) 
compared with positron emission tomography (13 to 15 cm) is 
a relative advantage for imaging patients with cardiomegaly. In 
addition, because imaging is performed with F-18 fluorodeoxy- 
glucose, there is no need to perform 24-h delayed imaging, as 
may be necessary for fixed defects when thallium-201 reinjec- 
tion is used to evaluate patients for the presence of hibernating 
myocardium. 
Limitations of rest F-18 fluorodeoxyglueose/stress Tc-99m 
MIBI dual-isotope SPECT. With the present protocol, stress- 
induced ischemia cannot be differentiated from hibernating 
myocardium. However, all patients with ischemic myocardium 
might benefit from revascularization whether it is stress in- 
duced or chronic in nature (14,15). 
One potential limitation of using F-18 fluorodeoxyglucose is 
encountered in patients with diabetes or a prediabetic condi- 
tion. Although administration of soluble insulin improves F-18 
fluorodeoxyglucose uptake by the myocardium, a significant 
number of patients with coronary artery disease are diabetic or 
prediabetic and demonstrate poor F-18 fluorodeoxyglucose 
uptake by the myocardium. Implementation f the euglycemic 
hyperinsulinemic clamp, which utilizes a simultaneous infusion 
of soluble insulin with a 10% dextrose solution to stimulate 
myocardial uptake of F-18 fluorodeoxyglucose, has resulted in 
excellent quality metabolic images in diabetic patients under- 
going dual-isotope SPECT in our laboratory (16). Utilization 
of the euglycemic hyperinsulinemic clamp increases both the 
cost and complexity of dual-isotope SPECT. However, this 
technique isequally applicable to diabetic patients undergoing 
cardiac F-18 fluorodeoxyglucose positron emission tomogra- 
phy to identify regions of injured but viable myocardium. 
Another limitation of the present study was that patients 
undergoing dual-isotope SPECT were not evaluated with 
thallium-201 reinjection scintigraphy for up to 24 h. In a recent 
study by Dreyfus et al. (15), among 50 patients initially referred 
for heart ransplantation, 46were identified as having myocar- 
dial viability and underwent coronary artery bypass grafting. 
All patients underwent initial evaluation with thallium-201 
reinjection scintigraphy for up to 24 h to identify injured but 
viable myocardium (25 of 46). Thirty-nine percent of patients 
with fixed thallium defects (18 of 46) were identified as having 
hibernating myocardium in at least two different vascular 
distributions by positron emission tomography and underwent 
successful coronary artery revascularization. 
The difference in attenuation between Tc-99m MIBI and 
F-18 fluorodeoxyglucose, especially by the diaphragm, should 
be recognized as a potential source of false positive study 
results with dual-isotope SPECr. In our experience, attenua- 
tion of F-18 fluorodeoxyglucose with dual-isotope SPECT has 
been insufficient to cause false positive metabolic study results. 
We are presently developing a method of attenuation correc- 
tion for Tc-99m MIBI for dual-isotope SPECT imaging. As a 
temporary solution, patients are imaged in the prone position 
whenever possible to minimize the number of false positive 
study results with dual-isotope SPECT secondary to diaphrag- 
matic attenuation. 
A limitation of the data provided from this study is the 
absence of outcome data. However, Bax et al. (17) recently 
demonstrated improved regional wall motion in 77% of mis- 
matched segments after revascularization in 15 patients who 
underwent both F-18 fluorodeoxyglucose SPECT and rest 
thallium-201 imaging. In the same study, 89% of matched 
defects howed no improvement in wall motion after revascu- 
larization. 
Conclusions. The results of the present s udy need to be 
confirmed in a larger series of patients with outcome monitoring. 
However, the use of rest F-18 fluorodeoxyglucose/stress Tc-99m 
MIBI dual-isotope SPECT may provide a cost-effective alterna- 
tive to N-13 ammonia/F-18 fluorodeoxyglucose cardiac positron 
emission tomography and a more accurate logistic method than 
thallium-201 reinjection t  identify injured or dysfunctional but 
viable myocardium. Although the data from the present study are 
comparable tothose from other adiopharmaceuticals for detect- 
ing acute myocardial ischemia, thepresent availability and cost of 
F-18 fluorodeoxyglucose will initially limit the utilization of dual- 
isotope SPECT to identifying those patients with injured but 
viable myocardium. 
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